Allurion Technologies director Douglas Hudson resigns
Allurion Technologies, Inc. reported that director Douglas Hudson, a Class II member of the board, resigned from the board and from the Nominating and Corporate Governance Committee effective June 30, 2026.
Rhea-AI Filing Summary
Allurion Technologies, Inc. reported that director Douglas Hudson, a Class II member of the board, resigned from the board and from the Nominating and Corporate Governance Committee effective June 30, 2026. The company stated that his resignation was not due to any disagreement with management, the board, or company policies or practices. The board is evaluating which current director will be appointed to replace him on the Nominating and Corporate Governance Committee.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Resignation effective date: June 30, 2026
8-K signature date: July 1, 2026
Common stock par value: $0.0001 per share
+2 more
5 metrics
Resignation effective date
June 30, 2026
Douglas Hudson’s board and committee resignation
8-K signature date
July 1, 2026
Signed by Legal Officer Brendan M. Gibbons
Common stock par value
$0.0001 per share
Allurion Technologies common stock
Warrant exercise price
$3,037.50 per share
Exercise price for ALUR WS warrants
Warrant share ratio
0.00378787 shares per warrant
Each ALUR WS warrant’s underlying common stock
Key Terms
Emerging growth company, Class II member of the board, Nominating and Corporate Governance Committee, par value, +1 more
5 terms
Emerging growth company regulatory
"Emerging growth company Item 5.02 Departure of Directors"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Class II member of the board financial
"Douglas Hudson, a Class II member of the board of directors"
Nominating and Corporate Governance Committee financial
"position on the Nominating and Corporate Governance Committee of the Board"
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
par value financial
"Common stock, par value $0.0001 per share"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
warrants financial
"Warrants to purchase 0.00378787 shares of common stock"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Allurion Technologies (ALUR) disclose in this 8-K filing?
Allurion Technologies disclosed that director Douglas Hudson resigned from its board and Nominating and Corporate Governance Committee effective June 30, 2026. The company noted his resignation was not due to any disagreement with management, the board, or the company’s operations, policies, or practices.
When did Allurion director Douglas Hudson’s resignation become effective?
Douglas Hudson’s resignation from Allurion’s board became effective on June 30, 2026. On that date, he stepped down as a Class II director and from the Nominating and Corporate Governance Committee, according to the company’s current report filed under Item 5.02.
How will Allurion Technologies fill the Nominating and Corporate Governance Committee seat?
Allurion Technologies said its board is evaluating which of its current directors will replace Douglas Hudson on the Nominating and Corporate Governance Committee. The filing does not yet name a successor, only indicating that the board is considering alternatives internally.
Who signed the Allurion Technologies 8-K reporting the director resignation?
The 8-K was signed on July 1, 2026, by Brendan M. Gibbons, identified as the company’s Legal Officer. His signature indicates the filing was duly authorized on behalf of Allurion Technologies under the Securities Exchange Act of 1934 requirements.
What securities of Allurion Technologies are listed in this disclosure?
The disclosure lists Allurion’s common stock with a par value of $0.0001 per share under the symbol ALUR, and warrants trading as ALUR WS. Each warrant is exercisable for 0.00378787 shares of common stock at an exercise price of $3,037.50 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
